COMMUNIQUÉS West-GlobeNewswire

IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid
05/08/2026
CHAMPIONS GATE, Fla., Aug. 05, 2026 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) strongly endorses a historic directive from the U.S. Department of Health and Human Services (HHS [...]
STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
05/08/2026
• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries • This strategic manufacturing investment is the largest in STERIS’s [...]
Bluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital Pharmacies
05/08/2026
Alexandria, Virginia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CostCheck, a drug procurement optimization tool used by more than 500 hospitals, now factors in top-line revenue alongside cost savings to provide pharmacy teams a [...]
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
05/08/2026
CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF ), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
05/08/2026
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 05, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of [...]
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
05/08/2026
Scottish National Investment Bank joins existing investors Roche Venture Fund, Epidarex Capital, Sofinnova Partners and BioGeneration Ventures Glasgow, Scotland, August 5, 2026 – Mironid, a biopharmaceutical company [...]
Grace Therapeutics Announces $10 Million Private Placement
05/08/2026
Expected gross proceeds anticipated to extend the Company’s cash runway to the end of calendar 2028 PRINCETON, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (“Grace Therapeutics” or “ [...]
ClinNEXUS Appoints John Stamatopoulos to New Position of Chief Growth Officer
04/08/2026
- Seasoned digital health growth executive with demonstrated ability to build revenue and drive disciplined expansion - LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, a data-driven healthcare company that’s [...]
FSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes
04/08/2026
CHICAGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has awarded $700,000 in grant funding to four awardees through its Early Career Fellowship and Established Investigator grant [...]
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
04/08/2026
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Pennant Acquires River Centre Assisted Living in Tucson, Arizona
04/08/2026
EAGLE, Idaho, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announces today that [...]
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
04/08/2026
Company continues its longstanding commitment to quality, safety, and regulatory excellence supporting the manufacture and distribution of XWRAP® SCOTTSDALE, Ariz., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
Acquisition of Own Shares
04/08/2026
Mechelen, Belgium; 04 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
04/08/2026
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
04/08/2026
– Total revenue of $73 million in 2Q26, a 92% year-over-year increase – – Revuforj ® (revumenib) net revenue of $54.7 million in 2Q26, a 91% year-over-year increase – – Niktimvo™ (axatilimab-csfr) net revenue of $60.3 [...]
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
04/08/2026
MONTREAL and CHARLOTTE, N.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Pacira BioSciences Reports Second Quarter 2026 Financial Results
04/08/2026
-- Continued execution of 5x30 strategy marked by solid revenue growth, durable cashflows, advancing pipeline, and high-caliber commercial partnerships -- -- Delivered second quarter total revenue of $192.4 million, [...]
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
04/08/2026
Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory [...]

Pages